199 related articles for article (PubMed ID: 33560194)
41. Hidradenitis suppurativa and Mediterranean fever gene mutations.
İlgen U; Yayla ME; Eyüpoğlu Ş; Karahan İ
JAAD Case Rep; 2019 Sep; 5(9):792-793. PubMed ID: 31528679
[No Abstract] [Full Text] [Related]
42. Clinical and genetic analysis of the first Mexican patient with a diagnosis of pyogenic sterile arthritis, pyoderma gangrenosum and acne (PAPA) syndrome.
Fuentes-Nava AG; Fierro-Arias L; Zenteno JC; Apam-Garduño D
Clin Exp Dermatol; 2024 Mar; 49(4):441-443. PubMed ID: 37942851
[No Abstract] [Full Text] [Related]
43. Hidradenitis Suppurativa in a Patient with Smith-Magenis Syndrome: A Case Report.
McKenzie SA; Ni CS; Hsiao JL
Cureus; 2019 Jun; 11(6):e4970. PubMed ID: 31453042
[TBL] [Abstract][Full Text] [Related]
44. Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa.
Fischer AH; Jourabchi N; Khalifian S; Lazarus GS
Wound Repair Regen; 2022 May; 30(3):338-344. PubMed ID: 35385180
[TBL] [Abstract][Full Text] [Related]
45. [Targeted therapy of pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome (PAPA): a case report and literature review].
Liang WL; Li HG; Zhong G; Wang BS; Ma JD; Chen JL; Mao HW; Yu-Lung YL; Lee PH
Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):977-981. PubMed ID: 33256319
[No Abstract] [Full Text] [Related]
46. Secukinumab for PASS syndrome: A new choice for therapeutic challenge?
Li M; Xiang H; Liang Y; Xue L; Zhou X; Yang L; Liu H; Yang M; Tang J; Li W
Dermatol Ther; 2022 Jul; 35(7):e15507. PubMed ID: 35419914
[TBL] [Abstract][Full Text] [Related]
47. Case Report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab.
Nikolakis G; Kreibich K; Vaiopoulos A; Kaleta K; Talas J; Becker M; Zouboulis CC
F1000Res; 2021; 10():381. PubMed ID: 34540202
[TBL] [Abstract][Full Text] [Related]
48. Identification of a homozygous PSTPIP1 mutation in a patient with a PAPA-like syndrome responding to canakinumab treatment.
Geusau A; Mothes-Luksch N; Nahavandi H; Pickl WF; Wise CA; Pourpak Z; Ponweiser E; Eckhart L; Sunder-Plassmann R
JAMA Dermatol; 2013 Feb; 149(2):209-15. PubMed ID: 23426477
[TBL] [Abstract][Full Text] [Related]
49. Phenotypes and Pathophysiology of Syndromic Hidradenitis Suppurativa: Different Faces of the Same Disease? A Systematic Review.
Nikolakis G; Kaleta KP; Vaiopoulos AG; Wolter K; Baroud S; Wojas-Pelc A; Zouboulis CC
Dermatology; 2021; 237(5):673-697. PubMed ID: 32942279
[TBL] [Abstract][Full Text] [Related]
50. Successful Treatment of PAPA Syndrome with Dual Adalimumab and Tacrolimus Therapy.
Sood AK; McShane DB; Googe PB; Wu EY
J Clin Immunol; 2019 Nov; 39(8):832-835. PubMed ID: 31471736
[No Abstract] [Full Text] [Related]
51. Overall and subgroup prevalence of pyoderma gangrenosum among patients with hidradenitis suppurativa: A population-based analysis in the United States.
Tannenbaum R; Strunk A; Garg A
J Am Acad Dermatol; 2019 Jun; 80(6):1533-1537. PubMed ID: 30738122
[TBL] [Abstract][Full Text] [Related]
52. PAPA and FMF in two siblings: possible amplification of clinical presentation? A case report.
Maggio MC; Ceccherini I; Grossi A; Gattorno M; Corsello G
Ital J Pediatr; 2019 Aug; 45(1):111. PubMed ID: 31443670
[TBL] [Abstract][Full Text] [Related]
53. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
54. Inflammation in mice ectopically expressing human Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne (PAPA) Syndrome-associated PSTPIP1 A230T mutant proteins.
Wang D; Höing S; Patterson HC; Ahmad UM; Rathinam VA; Rajewsky K; Fitzgerald KA; Golenbock DT
J Biol Chem; 2013 Feb; 288(7):4594-601. PubMed ID: 23293022
[TBL] [Abstract][Full Text] [Related]
55. Whole-Exome Sequencing in 10 Unrelated Patients with Syndromic Hidradenitis Suppurativa: A Preliminary Step for a Genotype-Phenotype Correlation.
Marzano AV; Genovese G; Moltrasio C; Tricarico PM; Gratton R; Piaserico S; Garcovich S; Boniotto M; Brandão L; Moura R; Crovella S
Dermatology; 2022; 238(5):860-869. PubMed ID: 35034021
[TBL] [Abstract][Full Text] [Related]
56. Interrupting an IFN-γ-dependent feedback loop in the syndrome of pyogenic arthritis with pyoderma gangrenosum and acne.
Lee W; Stone DL; Hoffmann P; Rosenzweig S; Tsai WL; Gadina M; Romeo T; Lee CR; Randazzo D; Pimpale Chavan P; Manthiram K; Canna S; Park YH; Ombrello AK; Aksentijevich I; Kastner DL; Chae JJ
Ann Rheum Dis; 2024 May; 83(6):787-798. PubMed ID: 38408849
[TBL] [Abstract][Full Text] [Related]
57. [Pyoderma gangrenosum associated with anti-proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) induced by propylthiouracil].
Coster A; Dargent JL; de Visscher N; Levecque P; Roquet-Gravy PP
Ann Dermatol Venereol; 2017 May; 144(5):368-373. PubMed ID: 28291538
[TBL] [Abstract][Full Text] [Related]
58. Is PASH Syndrome a Biofilm Disease?: A Case Series and Review of the Literature.
Ead JK; Snyder RJ; Wise J; Cuffy C; Jafary H; Fischborn K
Wounds; 2018 Aug; 30(8):216-223. PubMed ID: 30212364
[TBL] [Abstract][Full Text] [Related]
59. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation.
Marzano AV; Borghi A; Meroni PL; Cugno M
Br J Dermatol; 2016 Nov; 175(5):882-891. PubMed ID: 27106250
[TBL] [Abstract][Full Text] [Related]
60. PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome.
Calderón-Castrat X; Bancalari-Díaz D; Román-Curto C; Romo-Melgar A; Amorós-Cerdán D; Alcaraz-Mas LA; Fernández-López E; Cañueto J
Br J Dermatol; 2016 Jul; 175(1):194-8. PubMed ID: 26713508
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
